Simon and his colleagues found that DOG1 regulated the anti-angiogenic factor IGFBP5, leading to the modulation of IGF/IGFR signaling in the tumor microenvironment, which did not involve KIT expression and KIT-dependent pathways [32]. Here, IGFBP5 is linked to neoplasm.